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ABSTRACT
Background: Cardiovascular diseases and diabetes are among the leading causes of pre-
mature adult deaths in India. Innovative approaches such as clinical decision support (CDS)
software could play a major role in improving the quality of hypertension/diabetes care in
primary care settings.
Objective: To describe the steps and processes in the development of mWellcare, a complex
intervention based on mobile health (mHealth) technology.
Methods: The Medical Research Council framework was used to develop mWellcare in four
steps: (1) identify gaps in usual care through literature review and health facility assessments;
(2) identify the components of the intervention through discussions and consultations with
experts; (3) develop intervention (clinical algorithms and mHealth system); and (4) evaluate
acceptability and feasibility through pilot testing in five community health centers.
Results: Lack of evidence-based, integrated, and systematic management of chronic conditions
were major gaps identified. Experts in information technology, clinical fields, and public health
professionals identified intervention components to address these gaps. Thereafter, clinical
algorithm contextualized to primary care settings were prepared and the mWellcare interven-
tion was developed. During the 2-month pilot, 631 patients diagnosed with hypertension and/
or diabetes were registered, with a follow-up rate of 36.2%. The major barrier was resistance to
follow mWellcare recommended patient workflow, and to overcome it, we emphasized onsite
training and orientation program to cover all health care team member in each CHC.
Conclusion: A pilot-tested mWellcare intervention is an mHealth system with important
components, i.e. integrated management of chronic conditions, evidence-based CDS, long-
itudinal health data and automated short-messaging service to reinforce compliance to drug
intake and follow-up visit, which will be used by nurses at primary health care settings in
India. The effectiveness and cost-effectiveness of the intervention will be tested through a
cluster randomized trial (trial registration number NCT02480062).
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Background
Noncommunicable diseases (NCDs) account for
71% of global deaths, an increase of 14% from
2005 to 2015[1]. Three-fourths of these NCD deaths
occur in low and middle-income countries [2]. In
India, the probability of dying prematurely from the
four main NCDs is 26.2%; among the four main
NCDs, cardiovascular diseases (CVD) and diabetes
are leading causes [2]. The population level preva-
lence of hypertension and diabetes in adults in India
is high, with estimates of 23% [2] and 8.7% [3]
respectively. However, studies have shown that
management of hypertension, cardiovascular dis-
ease, and diabetes at primary care level is suboptimal
[4–7], and only half of the patients achieve their
target blood pressure and blood sugar level, which
increases their risk for CVD events [4,5]. Some of
the challenges in treating and managing chronic
conditions are suboptimal adherence to manage-
ment guidelines by the physicians [5,8], lack of reg-
ular patient monitoring and undiagnosed
comorbidities such as anxiety, depression, and alco-
hol use disorders which can contribute to failure to
follow treatment plans [9–11]. Mobile health
(mHealth) technologies are being advocated to
strengthen the health system, and systematic reviews
have shown that an mHealth-based Clinical
Decision Support System (CDSS) improves preven-
tive care and the physician’s clinical decision quality
in hypertension and diabetes management [8]
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although the evidence on their effects on cardiovas-
cular outcomes is limited [12].
Considering the potential of mobile technology to
address some of the challenges in chronic disease man-
agement, we sought to develop a tablet-computer-
enabled mHealth intervention (called mWellcare) with
the goal of integrated management of hypertension,
diabetes, and other comorbid conditions at the primary
health care level in India. This intervention is intended
to be used by general health care providers (nurses/
physicians) in primary care settings. The aim of this
paper is to describe the steps and processes in the
development and design of themWellcare intervention.
Methods
Study setting
Frontline public health facilities in rural India consist
of Primary Health Centers (population coverage
approximately 20,000–30,000) and community health
centers (CHCs) (population coverage approximately
80,000 – 120,000). Together these facilities cater to
the majority of the primary care needs in rural India
[13]. Under the National Program for prevention and
control of Cancer, Diabetes, Cardiovascular disease,
and Stroke (NPCDCS), NCD clinics are established at
CHCs for screening, diagnosis, and management of
common NCDs [14]. We based our study in CHCs in
two states of India, Haryana in the north and
Karnataka in the south. This study was approved by
the institutional Ethics Committee at Public Health
Foundation of India (PHFI) Reference No. TRC-IEC-
107/11 and London School of Hygiene and Tropical
Medicine (LSHTM) Reference No. 10,423.
Research framework
In order to describe the steps and processes in the
development and design of the mWellcare interven-
tion, we used the framework for the development of
‘complex’ interventions proposed by the Medical
Research Council (MRC), UK [15]. Based on this
framework, we followed the following steps: (1) iden-
tifying gaps in usual care, (2) identifying the compo-
nents of the intervention, (3) developing intervention
components, and (4) evaluating acceptability and fea-
sibility through pilot testing. We describe each step in
the sequence, demonstrating how findings from each
step were carried forward to subsequent steps.
Step 1: identifying gaps in usual care
We identified gaps in usual care through our previous
mHealth project experience [16–19], a literature review,
and situation analysis of a sample of health facilities. We
searched the PubMed database for peer-reviewed journal
articles assessing the gaps in the management of hyper-
tension and diabetes in India and other low- andmiddle-
income countries published from January 2000 to
December 2014. All possible combinations of the follow-
ing keywords were used: hypertension, diabetes mellitus,
clinical practice patterns, quality of health care, aware-
ness, control, treatment, management, prescription pat-
tern, adherence/compliance to medications, access to
care, barriers, delivery of health care, health care dispa-
rities, lifestyle, follow-up, medication, patient-centered
care, physician–patient relations, safety, primary, sec-
ondary, and tertiary care and India. We identified 1421
articles initially, of which 17 were relevant.
We conducted facility assessment at eight CHCs,
four each in Haryana and Karnataka, to assess existing
services, manpower, laboratory facilities, electricity,
infrastructure, information systems, and drug supply.
We also conducted semistructured interviews with phy-
sicians (n = 8), nurses (n = 6), other health functionaries
[n = 13 (counselor (3) + Pharmacist (4) + Lab techni-
cian (6)] at CHCs to assess the existing patient-manage-
ment practices, the extent of use of evidence-based
guidelines for management of hypertension and dia-
betes, and the barriers and measures to improve the
compliance to evidence-based guidelines by the health-
care team.
Step 2: identifying the components of the
intervention
We conducted consultation workshops (1) and meet-
ings (3) to discuss the gaps (identified in above steps)
with experts in information technology, clinical fields
(endocrinologist, cardiologist, and psychiatrist), pub-
lic health professionals, and government officials
working in the NCD program. The number of parti-
cipants in these meetings was from 10 to 25.
Step 3: development of intervention
The mWellcare intervention was developed into two
stages: (a) development of the clinical algorithms and
(b) development of the mHealth application.
Development of the clinical algorithms
The aim of this stage was to develop evidence-based
clinical algorithms for the management of hypertension
and diabetes and comorbid conditions (depression, alco-
hol use) for use at the primary health care level in India.
National and international experts in cardiology, endo-
crinology, and mental health reviewed the latest national
and international guidelines and selected those that were
considered most suitable for the context: the American
and International Society of Hypertension guidelines
2014 [20]; European Society of Hypertension 2013 [21];
WHO Guideline for Assessment and Management of
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Overall Cardiovascular Risk 2007 [22]; NICE guidelines
[23]; NPCDCS medical officer manual [24]; and the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-Specialized Health
Settings 2010 [25]. These guidelines were adapted based
on the available drugs and investigation facilities at the
CHCs located in Haryana and Karnataka.
Development of the application
After developing clinical algorithms, the team prepared
the software specification document that included the
detailed itemization of all questions and logic in the
application. Based on the spec document, a prototype
tablet-computer based application was developed by
Dimagi (software development agency for mWellcare)
on their CommCare platform. CommCare is an open-
source mHealth platform for frontline service delivery,
particularly in rural settings. It enables the execution of
evidence-based health logic through its mobile plat-
form, is scalable for large populations and will continue
to evolve so as to reduce long-term maintenance and
upgradation costs [26,27]. After internal testing of the
application for the accuracy of content and clinical
logic, multiple rounds of quality assurance (QA) testing
were carried out by an external quality assurance agency
(ValueLabs, Hyderabad, India) for user interface ele-
ments, Decision Support Recommendation (DSR) and
accuracy of patients’ longitudinal data. After extensive
iterative testing and refinement, the version for piloting
in the real-world was finalized. In addition, automated
short-messaging services (SMS) for self-management
and follow-up to be sent to patients from the central
server were developed and tested. Meetings between
experts from different disciplines (medical, health com-
munication, software, and telecom) were conducted to
develop the content of the SMS. In these meetings,
optimal content of the SMS in terms of language, type
(text, picture, voice), optimal frequency of the SMS
reminders, type of SMS reminders (drug intake and
follow-up reminders), the recipient (patient/family
member/friend) and alternative methods of reminders
for patients such as voice messages and telephonic
reminder were discussed, and SMS reminders were
finalized.
Step 4: pilot testing
The mWellcare intervention was piloted at five CHCs
(two in Haryana’s Mewat district and three in
Karnataka, two in Kolar district and one in Shimoga
district) during April to July 2015 on newly diag-
nosed and existing patients with hypertension and/
or diabetes. The objectives of pilot testing were: (1) to
assess the acceptability, feasibility, and user-friendli-
ness of the intervention, (2) to identify the barriers
and challenges in intervention delivery and strategies
to address them, and (3) to identify indicators for
monitoring intervention delivery.
The intervention was rolled out in three stages:
Stage 1: Setting up the intervention
This stage included obtaining information regarding
nurses to create their user profiles in the application.
Samsung tablets along with SIM cards, printers,
weighing machines, stadiometers, BP apparatus and
glucometers and strips for each CHCwere procured.
The mWellcare application was uploaded on the
Samsung tablet.
Stage 2: Training of physicians and nurses
We conducted 5-day training (3-day classroom and
2 days in-field) for nurses. The trainingwas conducted
in April and May 2015. In addition, a 1-day onsite
training of physicians was conducted in each CHC.
Stage 3: Observation and support
During the initial 3 days of mWellcare intervention
delivery by the nurses in the NCD clinic, onsite
observation and support were provided by the
research and Dimagi teams.
This was followed by a 2-month period of monitor-
ing and observation. The evaluation was completed by
interviewing physicians (n = 5) and nurses (n = 5),
obtaining field notes from the weekly observation visit
by the research and Dimagi teams, and analyzing
mobile user data from the central server. During this
period, we monitored the process indicators such as
number of new patients registered, follow-up rate,
proper assessment (review of DSR by the doctor) and
medication adherence.
Trial registration
The mWellcare trial is registered with Clinicaltrial.gov
(Registration number NCT02480062) and Clinical Trial
Registry of India (Registration number CTRI/2016/02/
006641).
Results
Gaps in usual care
Based on the literature review and facility assessment,
we identified the following gaps:
(1) Inadequate human capacity and resource:
While all the CHCs had general duty medical
officers, there were no dedicated doctors for
NCD care. Six CHCs had NCD nurses while
NCD counselors were available only in the
four CHCs of Karnataka. None of the NCD
nurses had received training to perform their
duties at the NCD clinic. Physicians at CHCs
reported limited access to evidence-based
guidelines for the management of hyperten-
sion and diabetes. They also reported limited
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training and knowledge update regarding
management of diabetes and hypertension.
(2) Lack of systematic patient assessment and
long-term management of chronic conditions:
The health facility assessment showed that
there is a lack of an organized system for
patient screening, registration, record keeping,
long-term follow-ups, monitoring of process
indicators, and QA at NCD clinics.
(3) Lack of integrated management of chronic con-
ditions: Screening of common mental disorders
and substance abuse is very rare in primary care,
even though alcohol use disorder and common
mental disorders like depression are associated
with CVD risk factors and can contribute to
failure to adhere to management plan among
people with hypertension and diabetes [28].
(4) Limited lifestyle advice: Physicians reported insuf-
ficient time to provide lifestyle advice and nurses
had limited training for providing the same.
Studies have shown insufficient diet control in
diabetes, insufficient physician time to motivate
and educate patients, reluctance or lack of moti-
vation of patient for drug adherence and lifestyle
changes as some of the reasons for suboptimal
control of hypertension and diabetes [28–30].
(5) Limited drug supply and diagnostics for hyper-
tension and diabetes management: Only two
classes of drugs for hypertension (beta blockers
and calcium channel blockers) and diabetes
(metformin and sulphonylureas) were available
at the CHCs. Supply of other classes of drugs was
irregular. While a sphygmomanometer and
glucometer were available at all the CHCs, the
supply of glucose test strips was inadequate.
Other studies from India and other low- and
middle-income countries have also shown simi-
lar deficiencies in drugs supply and equipment
in primary care settings [31,32].
Components of intervention
The consultation workshops and meetings led to the
consensus on adopting an integrated approach to
management of chronic condition rather than a dis-
ease-centric approach for patients with hypertension
and diabetes in primary care settings using an
mHealth application. Based on the consultation, com-
ponents of the mHealth intervention and the gap it
addressed were elaborated and synthesized (Table 1).
Intervention and its plan of delivery
The resulting mWellcare intervention is a mobile health
system consisting of a mobile component and a server
component. The mobile application is customized for
use by the primary care-based NCD nurse and doctor
for maintaining longitudinal health records, decision
support, patient case management, and generating a
checklist for lifestyle advice. The NPCDCS in India
has made provision for the NCD Nurse at the outpati-
ent clinics of CHCs. The intervention aims to use the
NCD Nurse for patient assessment and long-term fol-
low-up using the mWellcare system thereby shifting/
sharing some of the patient management tasks from
doctors. During the time when the gaps in usual care
were identified, doctors stated that they have a high
OPD patient load which could pose operational chal-
lenges in using technology by themselves, but they
showed positive interest in task shifting and having
access to guideline-based decision support. The web
interface of the system generates monitoring reports,
user/domain management, and data viewing and
extraction. A secondary user of the system is the patient.
Consenting patients may receive customized messaging
SMSmessages on their mobile devices. Figure 1 demon-
strates the architecture of themWellcare intervention in
terms of its functional components.
Table 1. Components of mWellcare intervention and the gaps in the usual care they address.
Component Description Gap addressed
Integrated management of
chronic conditions
Screening for CVD risk, depression, and alcohol dependence using
the CVD risk score, Patient Health Questionnaire (PHQ9) [33] and
Alcohol Use Disorder Identification Test (AUDIT) questionnaire
[34].
Lack of integrated management of chronic
conditions, addressing common multiple
morbidities
Evidence-based decision support
to physicians and other health
workers
Decision-support system to provide automated guideline-
recommended treatment plans, referral to specialist, and lifestyle
intervention tailored to individual patients
Inadequate human resource and capacity
Longitudinal health data All patients diagnosed with hypertension and diabetes are registered
and their clinical parameters recorded at every follow-up visit to
provide a longitudinal trend/summary of the clinical parameters
for decision-making
Lack of systematic patient assessment and
long-term management of the chronic
condition
Adherence support Automated Short-Messaging Service (SMS) from a central server to
reinforce compliance to drug intake and follow-up visit
Low adherence to long-term care
Lifestyle advice The nurse will provide lifestyle advice to the patients based on
relevant prompts provided by the application. All patients will be
provided a brochure in the local language on lifestyle changes.
Limited patient lifestyle changes
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Plan for delivery of the intervention
The application would be loaded on Samsung tablets
(Tab-A, AndroidOS). NCD nurses were expected to log
in to the application and register patients diagnosed
with hypertension and/or diabetes by the physician.
The NCD nurses would use the mWellcare system to
conduct the initial patient evaluation and generate a
printout of DSR. The patient would consult the physi-
cian with the DSR printout after initial evaluation by the
nurse. After the physician’s feedback on the DSR, the
patient would return to the NCD nurse, to update the
physician’s final decision on DSR in the mWellcare
application and receive lifestyle advice (Figure 2).
We anticipated resistance from the nurses, physi-
cians, and health administrators to use mWellcare, as
it involved significant changes in their workflow. We
thus incorporated a number of change-management
strategies including training and orientation of CHC
healthcare team on the application; explaining the
benefits of using mWellcare intervention for effective
management of NCDs; inviting health care team
Figure 1. Architecture of mWellcare.
Figure 2. mWellcare workflow.
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feedback for the refinement of intervention; regular
monitoring of the delivery of intervention through
both remote tracking of application data and in-per-
son visits; and involvement of higher level health
officials in bringing about changes in the existing
health system for effective delivery of intervention.
Pilot testing results
A total of 631 patients diagnosed with hypertension
and/or diabetes were registered during pilot testing.
Just over half were female (53%), the mean age was
59.7 years (58.8, 60.7), 65.6% of patients had hyperten-
sion, 14.7% had diabetes and 19.7% had both hyperten-
sion and diabetes. Physician agreement with
hypertension and diabetes DSRs were 61% and 70%,
respectively. The most common reason for disagree-
ment was the unavailability of drugs recommended by
the DSR. During the pilot, we observed that mWellcare
workflowwas not followed properly, because of a lack of
communication between pharmacist, registration desk,
nurses, and doctors regarding mWellcare intervention,
resulting in a low follow-up rate of patients at NCD
clinic. Out of 351 patients scheduled for the follow-up
visit (as per clinical parameters), only 127 (36.2%)
patients came back during the pilot testing period.
Patients who came back for follow-up were asked
about medication adherence, and we found that 98%
of the patients with hypertension were taking antihy-
pertensive medicines, and 61% of the patients with
diabeteswere taking antidiabeticmedication. In patients
with hypertension who came back for follow-up (119),
the mean SBP and DBP at baseline was 150.4 and 87.2
and at follow-up was 145.5 and 86 respectively. Owing
to the unavailability of glucometer strips at CHCs dur-
ing the pilot period, no test was done for blood sugars
during follow-up.We also observed that in 83% of cases,
doctors provided their feedback on the DSR.
Nurses reported that the mWellcare intervention
was helpful in performing their duties (for example,
searching for patients, structured assessments) and
improved their knowledge, skills, and ability to man-
age their workload. Physicians reported that the DSR
printout was useful as it has reduced time spent and
improved quality of patient assessment. Illustrative
quotes are appended below.
‘Yes it is helpful because we treat patients in a
different way now, so patients feel that staff are
more responsible and working hard’ (Nurse)
‘My working skills have improved because pre-
viously I never used to work like this. mWellcare
has helped me to learn new things’ (Nurse)
‘It has improved the quality of patient assessment, as it
provides the patient summary at a glance in theDSRprint
out, but the unavailability of the drug is the major chal-
lenge in following the recommendations’ (Physician)
‘DSR output is cluttered and the name of the
medicines is mentioned as the class name so we
find it difficult in thinking of the generic name.
DSR output should be made more readable, and the
generic name of the medicine should be mentioned
instead of the class name’ (Physician)
‘Patient assessment through this is time-consum-
ing; sometimes patients get irritated and we have long
queues in OPD’ (Nurse)
Table 2. Barriers encountered in the piloting of the mWellcare intervention and solutions.
Barrier Solutions
Application-related
Duplicate registration of patients Added fuzzy search (by name, father’s name, phone number, etc.) to
search for existing registered patient before opening new registration
form
Inappropriate nomenclature of forms Names of the forms were revised and replaced for the better
understanding of the health care team (for example, ‘Confirmation of
Treatment Plan’ form modified to ‘Record Prescription’ form)
Difficulty in administering the PHQ9 and AUDIT questionnaires in English Local languages (Hindi and Kannada) versions of the questionnaires
incorporated
DSR output and formatting issues, e.g. being lengthy and cluttered and
DSR generated class of drugs rather than the generic name of the
medicine
The printout was reformatted to make it visually appealing, clear, and less
cluttered. It provides information about the patient’s clinical
parameters over the previous five visits, current medication, previously
prescribed medication, recommended medications in their generic
names, and a reminder for lifestyle advice (Figure 3).
Knowledge and skills of nurses
Inability to use smart-phone/tabs Incorporated tablet handling, typing practice, and troubleshooting during
the training
Comorbid conditions assessment and management Training on comorbid conditions, including detection using PHQ9 and
AUDIT questionnaires and providing low-intensity behavioral
interventions, through role play and enhanced onsite support
Health-system barriers
Frequent changes in physician’s roster Develop an onsite training and orientation program to cover all
physicians in each CHC. Involve pharmacists and other supporting staff
for proper implementation of the mWellcare workflow.
Authorities reluctant to depute physicians for training owing to staff
shortage
Resistance to implementing mWellcare recommended workflow
Drugs not procured according to guidelines and unavailability of
glucometer strips
Mobilize assurance from higher health officials of state/districts to ensure
drug and glucometer strips availability
NCD nurse engaged in non-NCD work
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However, a number of barriers were observed and
potential solutions were elaborated, some of which were
tested during the piloting, as summarized in Table 2.
The major lessons from the pilot testing were that:
(1) for smooth implementation of mWellcare, the inter-
vention needs to be combinedwith workflow changes at
the CHCs; (2) there needs to be refresher training of the
nurses and other healthcare providers in the CHCs; (3)
features on the application were simplified to increase
acceptability by nurses and doctor.
Discussion
This paper describes the systematic development of
an mHealth intervention (mWellcare) aimed at inte-
grating the management of diabetes and hypertension
in primary care. Through our experience from our
earlier mhealth projects [16–19], health facility
assessments, and literature review, it was concluded
that a lack of systematic assessment and evidence-
based long-term management are the major reasons
for suboptimal treatment of hypertension and
diabetes in primary care. The mWellcare intervention
was intended to address these gaps and was designed
to optimize its utility, acceptability, and feasibility.
The intervention was further refined on the basis of
extensive pilot testing with the target users.
The final version of mWellcare application result-
ing from this development process will be used by
primary care nurses and doctors, and has the follow-
ing capabilities: to store and integrate longitudinal
health records electronically; to provide automated
guideline-recommended treatment plan, prompt
referral to specialist; to generate lifestyle intervention
tailored to patient clinical profile; to allow longitudi-
nal patient monitoring with alerts to the need for
changes in management; to send out automatic SMS
reminders and alerts to patients; to serve as a data-
collection tool for remote QA of NCD programs; and
to export standards-compliant healthcare data to rele-
vant receiving healthcare systems.
The mWellcare CDSS for hypertension and dia-
betes can successfully handle over 1000 permutations
of clinical profiles to generate personalized
Figure 3. mWellcare decision-support output.
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recommendations through the course of the patient’s
illness, for example revising drug recommendations if
control is poor and recommending treatments for
comorbid conditions. It also identifies permutations
outside its own scope and recommends consulting
with a specialist in such scenarios. Importantly,
these recommendations are also guided by CVD
risk profile assessments using the Framingham-Risk
Equation, which has been recalibrated for the Indian
population [35]. The intervention is delivered both
on the mobile application and web interface, with the
latter being used to store longitudinal patient data
and provide remote monitoring of patient and system
level implementation. The web interface also enables
the clinical management algorithms to be updated in
the event of new research findings on treatment
effectiveness. Once these changes have been con-
firmed and deployed, the mWellcare mobile applica-
tions are able to automatically download the updates
remotely. The mWellcare mobile application, in addi-
tion to prompts for patient inputs and the resultant
DSR, also provides a graphical display of a patient’s
longitudinal clinical parameters. Data about patients
can be shared between physicians and nurses either
electronically using android mobile devices or
through the system-customized printout. The
mWellcare system also generates personalized life-
style modification advice and also provides direct-
to-patient personalized behavior change messaging.
The mWellcare system platform is built with Python
using the Django web framework, the mobile appli-
cation is driven by an XML application configuration
layer with JavaRosa at the core, and the database is
CouchDB. The mWellcare mobile application is an
android application based on CommCare platform,
which can be downloaded through the Google play
store. It can work in the offline mode, but Internet
connectivity is required to sync the data with the
central server.
With regard to the scalability of the platform, the
system is in compliance with Electronic Health Record
Standards 2016, for Healthcare Information
Technology notified by Ministry of Health and Family
Welfare (MOHFW) [36]. Standards used in mWellcare
are: ICD 10 (International Statistical Classification of
Diseases and Related Health Problems 10th Revision)
for diagnosis, LOINC (Logical Observation Identifiers
Names and Codes) for lab results, UIDAI (Unique
Identity Authority of India) Aadhaar for patient identi-
fication, HL7 (Health Level-7) for messaging and
Continuity of Care Document for clinical document
exchange for interoperability. Thus, mWellcare is
enabled to be interoperable and send data to other
standards-compliant systems like a Diabetic Registry
or Integrated Health Information Platform. The appli-
cation also has a number of security features to ensure
confidentiality. In the mobile application, password-
protected access is enabled to restrict unauthorized
access. Only encrypted data are stored on the tablet.
Data no longer required on the mobile application are
purged from the device after submission to the server.
Only the subset of data required for future visits is
retained. On the server, all data are stored encrypted
at rest using Advanced Encryption Standard (AES) 256-
bit Symmetric Encryption. The server is Health
Insurance Portability and Accountability compliant,
and the infrastructure is hosted in a secure ISO 27,001
facility with biometric security. Data are backed up
every 24 h, and, in the event of a catastrophic failure,
the maximum period over which data would be lost
owing to a corruption issue on a server is 24 h.
The mWellcare intervention has several limitations.
ThemHealth application developed formWellcare inter-
vention is a postdiagnosis decision-support tool and can
only be used once the person is diagnosed with hyperten-
sion or diabetes by the physician. However, the current
version of the mWellcare application can be expanded to
include diagnostic functionality and to integrate with
external diagnostic devices. Keeping in mind the main-
tenance of the software and the management of the data,
the current application only permits central customiza-
tion, which may limit site-specific variations. As the
mWellcare application is based on the CommCare plat-
form, it is not as perfectly tailored to specific needs of the
target users as customized software could be; as one
example, the layout of fields on a single screen and
visualization options were limited owing to the rigid
structure of the templates on the platform and prede-
fined options for in-built reports. The benefits of custo-
mized software, for example, that users can dictate
exactly how they want their software to behave and
what reports should be implemented, was weighed
against the potential scalability and interoperability of
such customized software. Finally, the ability of
mWellcare to fully achieve its intended goals will always
be constrained by health system factors, such as avail-
ability of drugs and doctors at CHCs.
This is, to best of our knowledge, the first study
describing the development of an mHealth intervention
for integrated management of chronic conditions in a
low-resource setting. The resulting mWellcare inter-
vention aims to provide integrated management of
hypertension and diabetes at the primary care level
using evidence-based management protocols. The
cost-effectiveness of the intervention is currently being
evaluated in a cluster randomized controlled trial in
India (trial registration number NCT02480062).
Conclusion
Although the use of mHealth interventions is increas-
ing, the literature on their development and their
implementation is relatively scanty. This article
describes the major gaps in the chronic disease
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management at public primary care setting, how
these gaps can be addressed through the mHealth
intervention, steps for the development, and imple-
mentation of the intervention and evaluation of the
potential mhealth solution through pilot testing.
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